Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors: a systematic review
BPC-157 is a synthetic peptide studied for tissue repair and regenerative pathways in research models
Almost exclusively researchers in clinical trial settings, pharmacokinetic studies, and specialized research environments
156 It is a cofactor in more than 150 reactions in cells, including some involved in both folate and homocysteine metabolism
Saxenda (liraglutide): MHRA-approved
Overview New York, NY Nov 27, 2025 Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034